Diseases Flashcards
Hepadnaviridae; dsDNA, envelopes, 42nm. 70% asymptomatic. 30%: jaundice, right quadrant pain, 90% self-resolve. Antiviral drugs if necessary. Vaccine; immunoglobulin available.
Hepatitis B
Acid-fast rod. Airborne. Forms calcified tubercles in alveoli which rupture when immune system weakens. 6-month course of treatment. 33% of world population infected. Inconsistent vaccine effectiveness; not recommended in US.
Mycobacterium tuberculosis
Gram+; spore-forming; primarily zoological but can infect humans (inhalation, cutaneous, gastrointestinal). Negatively-charged capsule inhibits phagocytosis.Inhalation widens mediastinum. 22 terrorist-caused cases in 2001. Annual vacines available.
Bacillus anthracis
Acid-fast, Gram+ bacillus.Obligate parasite attaches to Schwann cells. Tuberculoid (mild) or Lepromatous (severe); mainly affects skin & nerves. Incubation period 3-5 years. Airborne. 90% of infections sucessfully defeated by immune system; no vaccine available.
Mycobacterium leprae
Gram- bacilli grow as biofilms on skin, in soil and water. Produces endotoxin and exotoxin. Antibiotic- and chlorine-resistant, causes swimming-associated rash; frequent nosocomial infections.
Pseudomonas aeruginosa
Gram+ spore-forming normal microflora. Triggered by antibiotic use, mainly in health care settings. Intestinal infection: diarrhea is body’s attempt to rid itself. Easily transmitted on hands and surfaces.
Clostridium difficile
dsDNA enveloped virus, pleiomorphic, 120-200nm. Target protein receptors on cell membrane and colonizes nerve cells near spinal cord. Usually asymptomatic; can cause fluid-filled blisters. Antiviral medications.
Herpesviridae
Gram+ cocci, cluster arrangement. Targets host cell membranes to cause skin and other infections. Multi-drug resistant opportunistic pathogen; normal nasal/skin flora.
Staphylococcus aureus
Gram+ spore-forming bacilli found in soil (spores) and in animal GI tracts. Produces 2 exotoxins; one (very potent) attaches to nerves & blocks neurotransmitter release to CNS causing chronic contraction, usu. beginning with neck & jaw muscles. Spores or bacteria enter wounds, but can only grow in anaerobic environment. Vaccine requires 5-year booster; no permanent immunity. Terminal endospores produce drumstick appearance.
Clostridium tetani
Non-enveloped polyhedral virus; over 100 strains (30 carcinogenic). Skin/mucous membrane infections. Proteins inactivate host’s tumor suppressor protein and cause uncontrolled cell division. Cancerous strains often asymptomatic. Usu eliminated by immune system prior to infection. Cell-mediated immunity failure delays activation of adaptive immunity. Over 110 million infected.
Human papillomavirus
Spore-forming Gram+ rod found in soil, moist sediment, and on fruits, veggies, seafood. Obligate anaerobe produces 2 exotoxins (very potent) which act at the neuromuscular junction to prevent aCh release, cause flaccid paralysis 7 toxigenic strains Mostly ingested; sometimes cutaneous. Extremely llethal. Antitoxins can have serious side effects. No immunity from exposure.
Clostridium botulinum
Capsulated Gram- diplococci. Usu affect the genitourinary tract, sometimes the pharynx or rectum. 50% females & 10% males asymptomatic.
Neisseria gonorrhoeae
Large brick-shaped virus localized in mouth, throat, and small blood vessels of skin. SPICE protein is virulence factor. Contact with infected items, fluids, occasionally airborne. Grows on mucous membranes, multiplies in lymph nodes, enters bloodstream. Causes pus-filled blisters that become pitted scars. Vaccines activate humoral & cellular immunity but lasts only 3-5 years.
Variola minor: Smallpox
Positive ssRNA virus; enveloped; spherical with spikes. Causes liver inflamation and cancer. 15-25% will clear the virus without treatment or chronic infections. No vaccine but immunity may exist. Multi-drug therapy necessary.
Hepatitis C virus
Helical ssRNA virus, very long, membranes stolen from host cell by budding. Systemic disease causes hemorrhagic fever and blood vessel damage, tuns course quickly. Transmitted through contact with infected patient, no treatment - 50-90% mortality.
Ebola virus